The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant Staphylococcus aureus Bacteriolysis

Bacteriophage-derived lysins are cell-wall-hydrolytic enzymes that represent a potential new class of antibacterial therapeutics in development to address burgeoning antimicrobial resistance. CF-301, the lead compound in this class, is in clinical development as an adjunctive treatment to potentiall...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Indiani, Chiara, Sauve, Karen, Raz, Assaf, Abdelhady, Wessam, Xiong, Yan Q., Cassino, Cara, Bayer, Arnold S., Schuch, Raymond
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2019
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437495/
https://ncbi.nlm.nih.gov/pubmed/30670427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02291-18
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items